Trending Now
---Advertisement---

Delhi health minister urges US firms to bring technology to India at affordable prices

Summarize with AI

---Advertisement---

New Delhi, Nov 19 Delhi Health Minister Pankaj Singh on Thursday urged US healthcare and pharmaceutical companies to bring their technologies to India at affordable prices, saying stronger Indo-US collaboration could help the country improve access to quality treatment.

Singh was addressing the 23rd Indo-US Economic Summit organised by the Indo-American Chamber of Commerce (IACC) here.

“Indian doctors and the pharmaceutical industry have made a name for themselves across the world. I would urge the US representatives present here today and the pharmaceutical companies to come to India with your technology at affordable prices. We welcome you, and together we can work towards strengthening the healthcare sector and providing affordable facilities to our people,” he said.

The summit featured discussions on strengthening India-US cooperation in healthcare, pharmaceuticals and life sciences.

US Embassy Health Attaché and Regional Representative for South Asia, Genessa Giorgi, highlighted the importance of strengthening pharmaceutical supply chains.

She said India plays an integral role in the global pharmaceutical supply chain and is the world’s largest provider of generic medicines, supplying over 40 per cent of the generic medicines consumed in the US.

Referring to the India-US Initiative on Critical and Emerging Technology (iCET), Giorgi said both countries are committed to strengthening supply chains and enhancing their resilience to future challenges.

She also highlighted investment opportunities through the SelectUSA initiative and USD 20 billion in investments announced by the US in May, of which USD 19.1 billion is meant for Indian pharmaceuticals and other sectors.

Henna Dhawan, Country Head, Public Affairs, Novartis India, said innovative medicines should be recognised for the breakthroughs they offer rather than for their cost.

“Healthcare is not a cost but an investment,” she said.

Bhuvnesh Shrivastava, Lead Corporate Affairs, OBU, AstraZeneca Pharma India Ltd, highlighted diversification as a key driver of growth in the pharmaceutical industry.

Ashish Kothari, Partner at Kochhar & Co, called for greater integration of artificial intelligence and law as AI-based tools increasingly find applications in medical diagnosis.

While technology is advancing rapidly, it also raises questions of liability, he said, calling for legal frameworks to keep pace with developments.

“Technology is catching up, so law also needs to catch up,” Kothari said.

Other speakers at the session included Sanjeev K Singh, Medical Director, Amrita Institute of Medical Sciences; Ravi Praful Valia, Director, Government Affairs, India Medtronic Pvt Ltd; and Gaurav Kaithwas, Director (Operations), UP Promote Pharma Council.

The session was chaired by Lokendra Gupta, Director, Emergency Medicine and Trauma Care, Vedanta Lucknow and President, SACTEM.

(PTI News)

Join WhatsApp

Join Now
---Advertisement---

Leave a Comment